Вы искали: inhibitorni (Хорватский - Английский)

inhibitorni učinak na maravirok.
cyp3a4 a net inhibitory effect on

igf-1 ima inhibitorni učinak na lučenje inzulina.
igf-1 has inhibitory effects on insulin secretion.

u nekim slučajevima, protutijela su pokazala inhibitorni učinak in vitro.
in some cases, the antibodies showed inhibitory effect in vitro.

inhibitorni učinci lapatiniba na rast procjenjivani su na staničnim linijama kondicioniranim trastuzumabom.
the growth inhibitory effects of lapatinib were evaluated in trastuzumab-conditioned cell lines.

inhibitorni učinak se održava tijekom 24 sata, a još uvijek se može izmjeriti do 48 sati.
the inhibitory effect is maintained over 24 hours and still measurable up to 48 hours.

bolesnicima s nedostatkom acth treba pažljivo prilagoditi nadomjestno liječenje glukokortikoidima kako bi se izbjegao bilo koji inhibitorni učinak na rast.
patients with acth deficiency should have their glucocorticoid replacement therapy carefully adjusted to avoid any inhibitory effect on growth.

analiza uzoraka plazme i mokraće ispitanika koji su primili indinavir pokazala je da metaboliti indinavira imaju slab inhibitorni učinak na proteinazu.
analysis of plasma and urine samples from subjects who received indinavir indicated that indinavir metabolites had little proteinase inhibitory activity.

zabilježeno je da je difenhidramin slab inhibitor aldehid oksidaze u jetri štakora, ali nisu poznati njegovi inhibitorni učinci u jetri ljudi.
diphenhydramine is reported to be a weak inhibitor of aldehyde oxidase in rat liver, but its inhibitory effects in human liver are not known.

ako pogledate njihove mozgove , vidjet ćete da su prepuni neurotransmitera koji su dobri u poticanju učenja i prilagodljivosti a inhibitorni se dijelovi nisu još pojavili .
and if you actually look in their brains , you see that they 're flooded with these neurotransmitters that are really good at inducing learning and plasticity , and the inhibitory parts haven 't come on yet .

kako fluoksetin ima sličan metabolički profil paroksetinu, tj. jak inhibitorni učinak na cyp2d6, može se očekivati sličan izostanak interakcija za fluoksetin.
since fluoxetine shares a similar metabolic profile with paroxetine, i.e. a strong cyp2d6 inhibitory effect, a similar lack of interaction would be expected for fluoxetine.

in vitro ispitivanja pokazuju da lenalidomid nema inhibitorni učinak na cyp1a2, cyp2c9, cyp2c19, cyp2d6, cyp2e1, cyp3a ili ugt1a1.
in vitro studies indicate that lenalidomide has no inhibitory effect on cyp1a2, cyp2c9, cyp2c19, cyp2d6, cyp2e1, cyp3a, or ugt1a1.

klinička ispitivanja u bolesnika s rakom dojke i koštanim metastazama pokazala su da postoji inhibitorni učinak na osteolizu kostiju ovisan o dozi, izražen biljezima resorpcije kostiju te učinak na koštane promjene ovisan o dozi.
clinical studies in patients with breast cancer and bone metastases have shown that there is a dose dependent inhibitory effect on bone osteolysis, expressed by markers of bone resorption, and a dose dependent effect on skeletal events.

klinička ispitivanja hiperkalcijemije povezane sa zloćudnim bolestima pokazala su da je inhibitorni učinak ibandronatne kiseline na osteolizu uzrokovanu tumorom, a osobito hiperkalcijemiju uzrokovanu tumorom, karakteriziran smanjenjem kalcija u serumu i izlučivanjem kalcija urinom.
clinical studies in hypercalcaemia of malignancy demonstrated that the inhibitory effect of ibandronic acid on tumour-induced osteolysis, and specifically on tumour-induced hypercalcaemia, is characterised by a decrease in serum calcium and urinary calcium excretion.

ispitivanje u odraslih štakora pokazalo je samo minimalan prolazan inhibitorni učinak na mineralnu gustoću kostiju, ali ne na bilo koje druge parametre relevantne za rast kostiju, što ukazuje da nema relevantnog učinka sakubitrila na kosti u populacijama odraslih bolesnika pod normalnim uvjetima.
a study in adult rats showed only a minimal transient inhibitory effect on bone mineral density but not on any other parameters relevant for bone growth, suggesting no relevant effect of sacubitril on bone in adult patient populations under normal conditions.

također, nije opažen značajni inhibitorni učinak u odnosu na placebo na agregaciju trombocita ili farmakokinetiku acetilsalicilne ili salicilne kiseline, kada je acetilsalicilna kiselina 150 mg/dan istodobno primijenjena nakon višestrukih doza vortioksetina u zdravih ispitanika.
also, no significant inhibitory effect, relative to placebo, on platelet aggregation or pharmacokinetics of acetylsalicylic acid or salicylic acid was observed when acetylsalicylic acid 150 mg/day was co-administered following multiple doses of vortioxetine administration in healthy subjects.

imatinib 400 mg dvaput na dan imao je inhibitorni učinak na metabolizam metoprolola posredovan cyp2d6, pri čemu su se cmax i auc metoprolola povećali za otprilike 23 % (90 %ci [1,16 -1,30]).
imatinib at 400 mg twice daily had an inhibitory effect on cyp2d6-mediated metoprolol metabolism, with metoprolol cmax and auc being increased by approximately 23 % (90 %ci [1.16 - 1.30]).